Mindray Medical International Limited (NYSE:MR), a leading Chinese medical device manufacturer, recently revealed that it has agreed to buy a majority holding in Hunan Changsha Tiandiren Biotech Co., Ltd. (“TDR”). The terms of the deal were not revealed as the agreement is not material to Mindray’s financial results.
TDR is a Chinese producer of microbiology analysis offerings focused on microbial identification, antibiotic susceptibility testing (“ID/AST”) as well as blood culture system. … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards